112 related articles for article (PubMed ID: 6507367)
21. DNA flow cytometry: a predictor of a high-risk group in cervical cancer.
Anton M; Nenutil R; Rejthar A; Kopecny J; Ptackova B; Zaloudik J
Cancer Detect Prev; 1997; 21(3):242-6. PubMed ID: 9167041
[TBL] [Abstract][Full Text] [Related]
22. [The study of DNA ploidy as a prognostic factor in uterine cervical cancer].
Watanabe Y; Ikeda M
Nihon Sanka Fujinka Gakkai Zasshi; 1992 Sep; 44(9):1127-34. PubMed ID: 1453042
[TBL] [Abstract][Full Text] [Related]
23. Carcinoma of the uterine cervix. I. Impact of prolongation of overall treatment time and timing of brachytherapy on outcome of radiation therapy.
Perez CA; Grigsby PW; Castro-Vita H; Lockett MA
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1275-88. PubMed ID: 7635767
[TBL] [Abstract][Full Text] [Related]
24. Flow cytometry and interactive image cytometry in endometrial carcinoma. A comparative and prognostic study.
Strang P; Stenkvist B; Bergström R; Stendahl U; Valdes del Campo M; Tribukait B
Anticancer Res; 1991; 11(2):783-8. PubMed ID: 2064334
[TBL] [Abstract][Full Text] [Related]
25. Prospective malignancy grading and flow cytometry DNA distribution in biopsy specimens from invasive squamous cell carcinoma of the uterine cervix.
Willén R; Tropé C; Långström E; Ranstam J; Killander D; Clase L
Anticancer Res; 1987; 7(2):235-42. PubMed ID: 3592637
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of DNA flow cytometry in the locally recurrent, conservatively treated breast cancer patient.
Haffty BG; Toth M; Flynn S; Fischer D; Carter D
J Clin Oncol; 1992 Dec; 10(12):1839-47. PubMed ID: 1453198
[TBL] [Abstract][Full Text] [Related]
27. Prospective malignancy grading, flow cytometry DNA-measurements and adjuvant chemotherapy for invasive squamous cell carcinoma of the uterine cervix.
Willén R; Himmelmann A; Långström-Einarsson E; Fernö M; Ranstam J; Baldetorp B; Skjaerris J; Prien-Larsen J; Tropé C; Stendahl U
Anticancer Res; 1993; 13(4):1187-96. PubMed ID: 8352543
[TBL] [Abstract][Full Text] [Related]
28. Prognosis of irradiated carcinoma of cervix uteri and nuclear DNA in cytologic postirradiation dysplasia.
Okagaki T; Meyer AA; Sciarra JJ
Cancer; 1974 Mar; 33(3):647-52. PubMed ID: 4592902
[No Abstract] [Full Text] [Related]
29. DNA cytometric analysis of surgically treated squamous cell cancer of the uterine cervix, stage pT1b1-pT2b.
Horn LC; Raptis G; Nenning H
Anal Quant Cytol Histol; 2002 Feb; 24(1):23-9. PubMed ID: 11865946
[TBL] [Abstract][Full Text] [Related]
30. The role of DNA index as a prognostic factor in early cervical carcinoma.
Nguyen HN; Sevin BU; Averette HE; Ganjei P; Perras J; Ramos R; Angioli R; Donato D; Penalver M
Gynecol Oncol; 1993 Jul; 50(1):54-9. PubMed ID: 8349165
[TBL] [Abstract][Full Text] [Related]
31. [Malignancy of hepatocellular carcinoma evaluated with nuclear DNA ploidy pattern].
Kamiyama T; Uchino J; Une Y; Ishizu H
Nihon Rinsho; 1992 Oct; 50(10):2408-12. PubMed ID: 1333017
[TBL] [Abstract][Full Text] [Related]
32. DNA ploidy, proliferation index, grade, and stage as prognostic factors for vulvar squamous cell carcinomas.
Dolan JR; McCall AR; Gooneratne S; Walter S; Lansky DM
Gynecol Oncol; 1993 Feb; 48(2):232-5. PubMed ID: 8428696
[TBL] [Abstract][Full Text] [Related]
33. Deoxyribonucleic acid content and survival rates of patients with transitional cell carcinoma of the bladder.
al-Abadi H; Nagel R
J Urol; 1994 Jan; 151(1):37-42. PubMed ID: 8254829
[TBL] [Abstract][Full Text] [Related]
34. Prognostic value of flow cytophotometric DNA content analysis in single treatment stage IB-IIA squamous cell carcinoma of the cervix.
Naus GJ; Zimmerman RL
Gynecol Oncol; 1991 Nov; 43(2):149-53. PubMed ID: 1743557
[TBL] [Abstract][Full Text] [Related]
35. Flow-cytometric DNA analysis of stages IB and IIA cervical carcinoma.
Zanetta GM; Katzmann JA; Keeney GL; Kinney WK; Cha SS; Podratz KC
Gynecol Oncol; 1992 Jul; 46(1):13-9. PubMed ID: 1634134
[TBL] [Abstract][Full Text] [Related]
36. Prospective analysis of DNA ploidy, proliferative index and epidermal growth factor receptor as prognostic factors for pretreated uterine cancer.
Nagai N; Oshita T; Fujii T; Kioka H; Katsube Y; Ohama K
Oncol Rep; 2000; 7(3):551-9. PubMed ID: 10767367
[TBL] [Abstract][Full Text] [Related]
37. DNA ploidy, grade, and stage in prognosis of uterine cervical cancer.
Davis JR; Aristizabal S; Way DL; Weiner SA; Hicks MJ; Hagaman RM
Gynecol Oncol; 1989 Jan; 32(1):4-7. PubMed ID: 2909446
[TBL] [Abstract][Full Text] [Related]
38. Transitional cell carcinoma of the renal pelvis and ureter: prognostic relevance of nuclear deoxyribonucleic acid ploidy studied by slide cytometry: an 8-year survival time study.
al-Abadi H; Nagel R
J Urol; 1992 Jul; 148(1):31-7. PubMed ID: 1613875
[TBL] [Abstract][Full Text] [Related]
39. Adenocarcinoma and mixed carcinoma of the uterine cervix. II. Prognostic value of nuclear DNA analysis.
Fu YS; Reagan JW; Fu AS; Janiga KE
Cancer; 1982 Jun; 49(12):2571-7. PubMed ID: 7074574
[TBL] [Abstract][Full Text] [Related]
40. DNA ploidy status as a prognostic marker and predictor of lymph node metastasis in laryngeal carcinoma.
Takes RP; Baatenburg de Jong RJ; van Blommestein R; Hermans J; van Krieken HH; Cornelisse CJ
Ann Otol Rhinol Laryngol; 2002 Nov; 111(11):1015-20. PubMed ID: 12450177
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
